Cellectis

Cellectis Non-Current Assets

The Non-Current Assets of Cellectis (CLLS) as of Oct 17, 2026 is -205.84 M USD. In the previous year, Non-Current Assets was -256.51 M USD — a change of -19.76% (higher).

Non-Current Assets

-205.84 MUSD

YoY

-19.76%

Last updated:

Non-Current Assets of Cellectis is 2025 -205.84 M USD. Non-Current Assets of Cellectis was 2024 -256.51 M USD. It decreases by -19.76% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cellectis Stock analysis

What does Cellectis do? Cellectis SA, headquartered in Paris, France, is a clinical-stage biotechnology company specializing in gene-editing technologies. It develops allogeneic CAR-T cell therapies for immuno-oncology, including product candidates like BALLI-01 for relapsed/refractory acute lymphoblastic leukemia and NatHaLi-01 for B-cell non-Hodgkin's lymphoma. The company also focuses on gene therapy for other therapeutic areas, with additional candidates targeting large B-cell lymphoma and renal cell carcinoma. Founded in 1999, it has 222 employees and has been listed on the stock market since 2007. Cellectis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cellectis stock

Non-Current Assets of Cellectis is -205.84 M USD in 2025.

Non-Current Assets of Cellectis changed from -256.51 M USD to -205.84 M USD, representing a -19.76% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Non-Current Assets Cellectis since 2006 – with annual values, charts, and detailed analysis.

Non-current assets are long-term resources not expected to be converted to cash within one year, including property, equipment, and long-term investments.

Non-Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Non-Current Assets's Cellectis historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Cellectis

All Key Metrics — Cellectis